Index - P/E 46.77 EPS (ttm) 1.73 Insider Own 9.62% Shs Outstand 29.57M Perf Week -3.36%
Market Cap 2.39B Forward P/E 52.00 EPS next Y 1.55 Insider Trans -0.46% Shs Float 26.73M Perf Month -4.54%
Enterprise Value 2.12B PEG 3.19 EPS next Q -0.20 Inst Own 106.65% Short Float 8.78% Perf Quarter -36.52%
Income 53.12M P/S 2.77 EPS this Y -41.05% Inst Trans -1.91% Short Ratio 2.27 Perf Half Y -50.21%
Sales 861.31M P/B 3.52 EPS next Y 50.51% ROA 6.94% Short Interest 2.35M Perf YTD -56.45%
Book/sh 22.92 P/C 7.93 EPS next 5Y 14.67% ROE 8.07% 52W High 218.52 -63.05% Perf Year -60.92%
Cash/sh 10.18 P/FCF 28.08 EPS past 3/5Y - - ROIC 7.50% 52W Low 73.92 9.23% Perf 3Y -59.06%
Dividend Est. - EV/EBITDA 40.61 Sales past 3/5Y 50.95% 57.80% Gross Margin 84.47% Volatility 4.59% 4.63% Perf 5Y -31.41%
Dividend TTM - EV/Sales 2.46 EPS Y/Y TTM 785.52% Oper. Margin 4.81% ATR (14) 4.74 Perf 10Y -
Dividend Ex-Date - Quick Ratio 4.84 Sales Y/Y TTM 22.05% Profit Margin 6.17% RSI (14) 35.73 Recom 2.00
Dividend Gr. 3/5Y - - Current Ratio 6.14 EPS Q/Q -137.80% SMA20 -8.33% Beta 1.19 Target Price 146.44
Payout 0.00% Debt/Eq 0.05 Sales Q/Q 10.82% SMA50 -22.78% Rel Volume 0.96 Prev Close 80.05
Employees 1246 LT Debt/Eq 0.05 Earnings Aug 04 AMC SMA200 -46.55% Avg Volume 1.03M Price 80.74
IPO May 03, 2018 Option/Short Yes / Yes EPS/Sales Surpr. 122.88% 1.31% Trades
Volume 995,650 Change 0.86%
Date
Action
Analyst
Rating Change
Price Target Change
Sep-02-25 Initiated Evercore ISI
Outperform
$150
Aug-05-25 Downgrade Truist
Buy → Hold
$125
Aug-05-25 Downgrade KeyBanc Capital Markets
Overweight → Sector Weight
Aug-05-25 Downgrade JP Morgan
Overweight → Neutral
$110
Nov-20-24 Upgrade BofA Securities
Neutral → Buy
$220 → $255
May-08-24 Downgrade BofA Securities
Buy → Neutral
$265 → $225
Apr-19-24 Initiated RBC Capital Mkts
Outperform
$285
Mar-19-24 Initiated Morgan Stanley
Overweight
$250
Feb-06-24 Resumed KeyBanc Capital Markets
Overweight
$278
Jan-19-24 Initiated Jefferies
Buy
$245
Jan-02-24 Downgrade Stifel
Buy → Hold
$210
Dec-13-23 Downgrade Wells Fargo
Overweight → Equal Weight
$245 → $187
Jul-19-23 Initiated Robert W. Baird
Outperform
$371
Apr-14-23 Initiated Mizuho
Buy
$300
Mar-29-23 Initiated UBS
Buy
$300
Dec-13-22 Upgrade Goldman
Neutral → Buy
$245 → $308
Dec-13-22 Initiated KeyBanc Capital Markets
Overweight
$287
Apr-13-22 Initiated Truist
Buy
$315
Apr-06-22 Initiated Wolfe Research
Peer Perform
$270
Mar-02-22 Resumed BofA Securities
Buy
$270
Show Previous Ratings
Sep-12-25 08:37AM
Sep-08-25 03:43PM
Sep-03-25 11:36PM
03:45PM
11:30AM
09:45AM
Loading…
Sep-02-25 09:45AM
Aug-28-25 06:33AM
Aug-27-25 12:32PM
Aug-26-25 04:30PM
Aug-22-25 08:21AM
Aug-20-25 08:00AM
Aug-15-25 02:55PM
10:10AM
Aug-13-25 03:00PM
12:04AM
12:01AM
Loading…
12:01AM
Aug-12-25 02:20PM
Aug-11-25 04:35PM
08:00AM
Aug-07-25 01:01PM
Aug-06-25 10:18PM
12:23PM
Aug-05-25 12:41PM
11:38AM
09:37AM
09:35AM
(Investor's Business Daily)
05:49AM
03:05AM
Aug-04-25 06:30PM
06:05PM
05:05PM
Loading…
05:05PM
(Associated Press Finance)
04:31PM
04:02PM
Aug-02-25 11:02PM
Aug-01-25 08:50AM
07:40AM
Jul-31-25 10:00AM
07:32AM
Jul-30-25 01:09PM
Jul-28-25 10:00AM
Jul-16-25 08:50AM
12:06AM
Jul-15-25 08:50AM
Jul-07-25 10:14AM
08:00AM
Jun-13-25 11:21AM
08:27AM
Jun-12-25 12:59PM
Jun-11-25 09:51AM
Jun-06-25 09:02AM
Jun-04-25 11:30AM
Jun-03-25 08:00AM
Jun-02-25 10:23AM
May-30-25 08:00AM
May-29-25 08:47AM
May-27-25 08:15AM
May-26-25 08:30AM
08:30AM
May-22-25 06:46AM
06:38AM
May-21-25 07:49AM
May-20-25 08:53AM
May-15-25 08:55AM
May-08-25 09:50AM
May-07-25 12:00PM
09:55AM
May-06-25 12:29PM
08:36AM
(Thomson Reuters StreetEvents)
03:08AM
May-05-25 06:54PM
05:10PM
04:02PM
May-02-25 10:56AM
09:20AM
Apr-29-25 08:00AM
Apr-21-25 08:00AM
Apr-01-25 08:00AM
Mar-12-25 11:30AM
Mar-11-25 05:04AM
Mar-06-25 08:00AM
Mar-04-25 11:53PM
08:06AM
Feb-28-25 04:03AM
Feb-25-25 02:53PM
09:50AM
Feb-12-25 09:45AM
Feb-11-25 08:40AM
(Thomson Reuters StreetEvents)
07:01AM
02:08AM
Feb-10-25 05:30PM
05:10PM
04:19PM
04:02PM
Feb-09-25 08:02AM
Feb-07-25 07:07AM
Feb-05-25 09:15AM
Feb-03-25 10:00AM
Jan-13-25 06:45AM
Jan-09-25 07:30AM
(Investor's Business Daily)
Jan-07-25 09:50AM
Inspire Medical Systems, Inc. is a medical technology company, which focuses on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. The firm offers inspire therapy, which consists of a remote control and implantable components that includes pressure sensing lead, a neurostimulator, and a stimulation lead. It operates through the United States and All Other Countries geographical segments. The company was founded by Timothy P. Herbert in November 2007 and is headquartered in Golden Valley, MN.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Buchholz Richard Chief Financial Officer Aug 29 '25 Sale 93.39 11,000 1,027,290 44,867 Sep 02 08:14 PM Buchholz Richard Officer Aug 29 '25 Proposed Sale 93.40 11,000 1,027,349 Aug 29 04:49 PM Buchholz Richard Chief Financial Officer Aug 19 '25 Option Exercise 62.74 25,008 1,569,031 61,247 Aug 21 04:05 PM mcCormick Shawn Director Jun 04 '25 Option Exercise 16.00 4,000 64,000 28,046 Jun 06 06:06 PM Rondoni John See Remarks May 19 '25 Sale 149.38 1,734 259,025 13,766 May 21 04:05 PM JOHN RONDONI Officer May 19 '25 Proposed Sale 149.38 1,734 259,025 May 19 04:01 PM mcCormick Shawn Director May 02 '25 Sale 160.00 360 57,600 24,046 May 05 07:31 PM SHAWN T MCCORMICK Director May 02 '25 Proposed Sale 157.90 360 56,844 May 02 04:23 PM Ban Randy See Remarks Mar 03 '25 Sale 185.84 3,947 733,496 7,259 Mar 05 04:47 PM Rondoni John Chief Technology Officer Mar 03 '25 Sale 185.60 2,287 424,467 15,500 Mar 05 04:46 PM JOHN RONDONI Officer Mar 03 '25 Proposed Sale 185.60 2,287 424,467 Mar 03 04:27 PM RANDALL BAN Officer Feb 28 '25 Proposed Sale 184.02 3,947 726,327 Feb 28 04:18 PM Ban Randy See Remarks Feb 13 '25 Option Exercise 67.63 25,000 1,690,750 32,843 Feb 18 06:44 PM Ban Randy See Remarks Feb 13 '25 Sale 183.50 25,584 4,694,766 7,259 Feb 18 06:44 PM Rondoni John Chief Technology Officer Feb 11 '25 Sale 170.49 583 99,396 10,424 Feb 13 08:14 PM RANDALL BAN Officer Feb 13 '25 Proposed Sale 187.01 25,584 4,784,464 Feb 13 04:30 PM JOHN RONDONI Officer Feb 11 '25 Proposed Sale 170.49 583 99,396 Feb 11 04:01 PM Rondoni John Chief Technology Officer Jan 07 '25 Sale 215.00 58 12,470 11,322 Jan 10 04:05 PM JOHN RONDONI Officer Jan 07 '25 Proposed Sale 215.00 58 12,470 Jan 07 04:02 PM Rondoni John Chief Technology Officer Nov 01 '24 Option Exercise 61.38 8,703 534,219 20,051 Nov 05 04:01 PM Rondoni John Chief Technology Officer Nov 01 '24 Sale 193.47 8,703 1,683,731 11,348 Nov 05 04:01 PM JOHN RONDONI Officer Nov 01 '24 Proposed Sale 193.46 8,703 1,683,723 Nov 01 04:47 PM
